A case study on efficacy of Virechana Karma by Phalatrikadi Kwatha in management of Dyslipidemia
Abstract
Dyslipidaemia itself harbour many future deadly diseases. Every 1% increase in cholesterol level is responsible for 1-2% increase in the incidence of Coronary Heart Disease. It is a lifestyle metabolic disorder because of faulty food habits, minimum physical exercise , stress etc. As there is no direct reference of Dyslipidaemia in Ayurveda . But due to resemblance of its etiopathogenesis and clinical features, it may come under broad umbrella of Santarpanjanyavyadhi, Medopradoshaja Vikara and Medosroto Dusti. Virechana Karma is line of treatment for Santarpanajanya Vyadhi and Bahudoshawastha. The aim of this study was to treat Dyslipidemia with Virechana Karma. Lipid profile was opted for the assessment of Dyslipidaemia before and after the treatment. Phalatrikadi Kwatha was chosen as Virechana Karma drug as its contents has hypolipidemic properties. The present case had 24 years old female with complaints of weight gain, fatigue, drowsiness, heaviness in the body, hyperacidity since 4 years. Before Virechana Karma, total cholesterol, VLDL & triglyceride levels were high. After Virechana Karma, significant result was found on the level of total cholesterol, VLDL & triglyceride. There was complete remission of symptoms. Patient lost 7 kg of weight. This improvement may be due to the correction of Agni by Virechana Karma and removal of abnormal lipids from body and Ruksha, Tikshna, Srotoshodhaka, Lekhana, Kaphamedahar, Agnivardhaka properties of Phalatrikadi Kwatha. Hence from this study it can be concluded that, Virechana Karma is effective and can be safely used in the management of Dyslipidaemia.
Downloads
References
Mohan H. The blooad vessels and lymphatics. In: Textbook of Pathology. 7th ed. Jaypee publisher; p. 374.
Braunwald E, FanciAS,Hauser SL, Kasper DL, Longo DL, Jameson JL, Harrison TR. Harrison’s Principles of Internal Medicines, 12th International Edition.,New York: Mc Graw-Hill Medical Publishing Division,Vol. I, 2002. In.
Tapan Ghose, Handbook of lipidology, jaypee brother’s medical publishers (P) Ltd; 71. WHO diet related risk factors (2002) Available from:http://who.int/whr/2002/chapter4/en/index4. In.
WHO diet related risk factors (2002) Available from:http://who.int/whr/2002/chapter4/en/index4.
Sample registration system (2007) million death study: Preliminary report on causes of death in India 2001-2003. New Delhi: Registrar general of India. Mohan H. The blooad vessels and lymphatics. In: Textbook of Pathology. 7th ed. Jaypee publisher; p. 374.
Braunwald E, FanciAS,Hauser SL, Kasper DL, Longo DL, Jameson JL, Harrison TR. Harrison’s Principles of Internal Medicines, 12th International Edition.,New York: Mc Graw-Hill Medical Publishing Division,Vol. I, 2002. In.
Tapan Ghose, Handbook of lipidology, jaypee brother’s medical publishers (P) Ltd; 71. WHO diet related risk factors (2002) Available from:http://who.int/whr/2002/chapter4/en/index4. In.
WHO diet related risk factors (2002) Available from:http://who.int/whr/2002/chapter4/en/index4.
Sample registration system (2007) million death study: Preliminary report on causes of death in India 2001-2003. New Delhi: Registrar general of India.
Ashtang Samgraha of Vagbhata (text, English translation, notes, indeces etc.) translated by Prof. K.R. Srikantha Murthy vol.1publication by Chaukhambha orientalia, Varanasi. edition- 9th 2005 chapter 19 pg. no. 352. In.
Sastri K. Atisthula. In: Charak samhita. 2011th ed. Varanasi: Chaukhambha Publication; p. 279.
Ashtang Samgraha of Vagbhata (text, English translation, notes, indeces etc.) translated by Prof. K.R. Srikantha Murthy vol.1publication by Chaukhambha orientalia, Varanasi. edition- 9th 2005 chapter 19 pg. no. 351. In.
Sastri K. Virechana Karma. In: Charak samhita. Reprint 2011. Varanasi: Chaukhambha Publication; p. 296.
Sastri K. Atisthula chikitsa. In: Charak samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 272.
Sastri A dutt. Pitta sthana. In: Sushruta samhita. Reprint 2018. Varanasi: Chaukhambha Publication; p. 181.
Sastri K. Virechana Karma samyak lakshan. In: Charak samhita. Reprint 2011. Varanasi: Chaukhambha Publication; p. 964.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. PMID: 12485966.
Sastri K. Prameha. In: Charak Samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 430.
Seo MH, Bae JC, Park SE, Rhee EJ, Park CY, Oh KW, et al. Association of Lipid and Lipoprotein Profiles with Future Development of Type 2 Diabetes in Nondiabetic Korean Subjects: A 4-Year Retrospective, Longitudinal Study. J Clin Endocrinol Metab. 2011 Dec 1;96(12):E2050–4.
Sastri K. Lekhana via shodhan. In: Charak samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 291.
Sastri K. Medogata jwara chikitsa. In: Charak samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 171.
Rakshita Vijaya, Datta Shrikanta., editors. Madhava Nidana (Madhukosha) of Madhavakara. Edition Second. Ch. 33, Ver. 13-14. Varanasi: Varanaseya Sanskrit Samsthana; 1993. P. 28. In.
Mohan H. The blooad vessels and lymphatics. In: Textbook of Pathology. 7th ed. Jaypee publisher; p. 374.
Braunwald E, FanciAS,Hauser SL, Kasper DL, Longo DL, Jameson JL, Harrison TR. Harrison’s Principles of Internal Medicines, 12th International Edition.,New York: Mc Graw-Hill Medical Publishing Division,Vol. I, 2002. In.
Tapan Ghose, Handbook of lipidology, jaypee brother’s medical publishers (P) Ltd; 71. WHO diet related risk factors (2002) Available from:http://who.int/whr/2002/chapter4/en/index4. In.
WHO diet related risk factors (2002) Available from:http://who.int/whr/2002/chapter4/en/index4.
Sample registration system (2007) million death study: Preliminary report on causes of death in India 2001-2003. New Delhi: Registrar general of India.
Ashtang Samgraha of Vagbhata (text, English translation, notes, indeces etc.) translated by Prof. K.R. Srikantha Murthy vol.1publication by Chaukhambha orientalia, Varanasi. edition- 9th 2005 chapter 19 pg. no. 352. In.
Sastri K. Atisthula. In: Charak samhita. 2011th ed. Varanasi: Chaukhambha Publication; p. 279.
Ashtang Samgraha of Vagbhata (text, English translation, notes, indeces etc.) translated by Prof. K.R. Srikantha Murthy vol.1publication by Chaukhambha orientalia, Varanasi. edition- 9th 2005 chapter 19 pg. no. 351. In.
Sastri K. Virechana Karma. In: Charak samhita. Reprint 2011. Varanasi: Chaukhambha Publication; p. 296.
Sastri K. Atisthula chikitsa. In: Charak samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 272.
Sastri A dutt. Pitta sthana. In: Sushruta samhita. Reprint 2018. Varanasi: Chaukhambha Publication; p. 181.
Sastri K. Virechana Karma samyak lakshan. In: Charak samhita. Reprint 2011. Varanasi: Chaukhambha Publication; p. 964.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002 Dec 17;106(25):3143-421. PMID: 12485966.
Sastri K. Prameha. In: Charak Samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 430.
Seo MH, Bae JC, Park SE, Rhee EJ, Park CY, Oh KW, et al. Association of Lipid and Lipoprotein Profiles with Future Development of Type 2 Diabetes in Nondiabetic Korean Subjects: A 4-Year Retrospective, Longitudinal Study. J Clin Endocrinol Metab. 2011 Dec 1;96(12):E2050–4.
Sastri K. Lekhana via shodhan. In: Charak samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 291.
Sastri K. Medogata jwara chikitsa. In: Charak samhita. reprint 2011. Varanasi: Chaukhambha Publication; p. 171.
Rakshita Vijaya, Datta Shrikanta., editors. Madhava Nidana (Madhukosha) of Madhavakara. Edition Second. Ch. 33, Ver. 13-14. Varanasi: Varanaseya Sanskrit Samsthana; 1993. P. 28. In.
Kasture H shridhar. Virechana Karma. In: Ayurvediya panchakarma vigyan. 2014th ed. Allahabad: Shri Baidyanath ayurved; p. 333.
Chunekar K. Musta. In: Bhavprakash nighantu. Reprint 2018. Varanasi: Chaukhambha Publication; p. 232.
Dominic AA, Parkavi C, Murugaiah K, Dhanaraj TS. Hypolipidemic activity of Cyperous rotundus on CCl4 induced dyslipidemia in rats. Asian Journal of Pharmacy and Technology. 2012;2(2):51-3.
Chunekar K. Indrayana. In: Bhavprakash nighantu. Reprint 2018. Chaukhambha Publication; p. 389.
Milgate, J., & Roberts, D.C. (1995). The nutritional & biological significance of saponins. Nutrition Research, 15, 1223-1249.
Chunekar K. Haridra. In: Bhavprakash nighantu. Reprint 2018. Chaukhambha Publication; p. 111.
Chunekar K. Daruharidra. In: Bhavprakash nighantu. Reprint 2018. Chaukhambha Publication; p. 114.
Derosa G, Bonaventura A, Bianchi L, Romano D, D’Angelo A, Fogari E, et al. Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients. Expert Opin Biol Ther. 2013 Nov 1;13(11):1495–506.
Chunekar K. Triphla. In: Bhavprakash Nighantu. Reprint 2018. Varanasi: Chaukhambha Publication;p. 12
Selvaraj Saravanan, Ramasundaram Srikumar, Sundarmahalingam Manikandan, Narayan Perumal Jeya Parthasarathy and Rathinaswamy Sheela Devi, Hypolipidemic Effect of Triphala in Experimentally Induced Hypercholesteremic Rats, Yakugaku Zasshi 127(2) 2007 The Pharmaceutical Society of Japan 385-388.
Copyright (c) 2022 Megha Nautiyal, Prof. Arun Gupta, Neha Yadav
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
